Your browser doesn't support javascript.
loading
Prognostic impact of cytogenetic aberrations in AL amyloidosis patients after high-dose melphalan: a long-term follow-up study.
Bochtler, Tilmann; Hegenbart, Ute; Kunz, Christina; Benner, Axel; Kimmich, Christoph; Seckinger, Anja; Hose, Dirk; Goldschmidt, Hartmut; Granzow, Martin; Dreger, Peter; Ho, Anthony D; Jauch, Anna; Schönland, Stefan O.
Afiliación
  • Bochtler T; Amyloidosis Center, and Division of Hematology/Oncology/Rheumatology, Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany;
  • Hegenbart U; Amyloidosis Center, and Division of Hematology/Oncology/Rheumatology, Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany;
  • Kunz C; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany;
  • Benner A; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany;
  • Kimmich C; Amyloidosis Center, and Division of Hematology/Oncology/Rheumatology, Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany;
  • Seckinger A; Division of Hematology/Oncology/Rheumatology, Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany;
  • Hose D; Division of Hematology/Oncology/Rheumatology, Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany;
  • Goldschmidt H; Division of Hematology/Oncology/Rheumatology, Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, Heidelberg, Germany; and.
  • Granzow M; Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
  • Dreger P; Division of Hematology/Oncology/Rheumatology, Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany;
  • Ho AD; Amyloidosis Center, and Division of Hematology/Oncology/Rheumatology, Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany;
  • Jauch A; Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
  • Schönland SO; Amyloidosis Center, and Division of Hematology/Oncology/Rheumatology, Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany;
Blood ; 128(4): 594-602, 2016 07 28.
Article en En | MEDLINE | ID: mdl-27257181
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Aberraciones Cromosómicas / Cromosomas Humanos / Cadenas Ligeras de Inmunoglobulina / Trasplante de Células Madre Hematopoyéticas / Amiloidosis / Melfalán Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Aberraciones Cromosómicas / Cromosomas Humanos / Cadenas Ligeras de Inmunoglobulina / Trasplante de Células Madre Hematopoyéticas / Amiloidosis / Melfalán Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2016 Tipo del documento: Article